Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-23

Clinical Trial Update: Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia

View source ↗

Summary

Clinical trial update indicating Enavogliflozin is recruiting for a study in adults with Type 2 diabetes mellitus, with hypertension or dyslipidemia, to evaluat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enavogliflozin (enavogliflozin)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Diabetes Mellitus, Type 2 | Status: RECRUITING